The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples
Brock O’Neil(Vanderbilt University), David F. Penson(Geriatric Research Education and Clinical Center), Peter C. Albertsen(UConn Health), Richard M. Hoffman(University of Iowa), Ralph Conwill(Vanderbilt-Ingram Cancer Center), Tatsuki Koyama(Vanderbilt University Medical Center), Janet L. Stanford, Sherrie H. Kaplan(University of California, Irvine), Daniel A. Barocas(Vanderbilt University Medical Center), Sheldon Greenfield(University of California, Irvine), Lisa E. Paddock(Rutgers, The State University of New Jersey), Matthew R. Cooperberg(University of California, San Francisco), Ann S. Hamilton(University of Southern California), Karen E. Hoffman(The University of Texas MD Anderson Cancer Center), Robert A. Stephenson(University of Utah), Xiao‐Cheng Wu(Louisiana State University Health Sciences Center New Orleans), JoAnn Alvarez(University of Bonn), Antoinette M. Stroup(Rutgers, The State University of New Jersey), Matthew J. Resnick(Vanderbilt University Medical Center), Michael Goodman(Emory University)
Cited by 64
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656